217 related articles for article (PubMed ID: 38088165)
21. Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy.
Wu Y; Feng L
Expert Opin Drug Deliv; 2023 Mar; 20(3):323-333. PubMed ID: 36634017
[TBL] [Abstract][Full Text] [Related]
22. Research progress of neoantigens in gynecologic cancers.
Song Y; Zhang Y
Int Immunopharmacol; 2022 Nov; 112():109236. PubMed ID: 36113318
[TBL] [Abstract][Full Text] [Related]
23. Neoantigens: promising targets for cancer therapy.
Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
[TBL] [Abstract][Full Text] [Related]
24. The perfect personalized cancer therapy: cancer vaccines against neoantigens.
Aurisicchio L; Pallocca M; Ciliberto G; Palombo F
J Exp Clin Cancer Res; 2018 Apr; 37(1):86. PubMed ID: 29678194
[TBL] [Abstract][Full Text] [Related]
25. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.
Li J; Xiao Z; Wang D; Jia L; Nie S; Zeng X; Hu W
Mol Cancer; 2023 Aug; 22(1):141. PubMed ID: 37649123
[TBL] [Abstract][Full Text] [Related]
26. Neoantigen cancer vaccines: a new star on the horizon.
Li X; You J; Hong L; Liu W; Guo P; Hao X
Cancer Biol Med; 2023 Dec; 21(4):274-311. PubMed ID: 38164734
[TBL] [Abstract][Full Text] [Related]
27. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
[TBL] [Abstract][Full Text] [Related]
28. Determinants for Neoantigen Identification.
Garcia-Garijo A; Fajardo CA; Gros A
Front Immunol; 2019; 10():1392. PubMed ID: 31293573
[TBL] [Abstract][Full Text] [Related]
29. Neoantigen: A New Breakthrough in Tumor Immunotherapy.
Zhang Z; Lu M; Qin Y; Gao W; Tao L; Su W; Zhong J
Front Immunol; 2021; 12():672356. PubMed ID: 33936118
[TBL] [Abstract][Full Text] [Related]
30. Immune Checkpoint Blockade Enhances Efficacy of Neoantigen Vaccine.
Cancer Discov; 2022 Jun; 12(6):1408. PubMed ID: 35426915
[TBL] [Abstract][Full Text] [Related]
31. Targeting neoantigens for cancer immunotherapy.
Lu YC; Robbins PF
Int Immunol; 2016 Jul; 28(7):365-70. PubMed ID: 27208041
[TBL] [Abstract][Full Text] [Related]
32. Neoantigen vaccine: an emerging tumor immunotherapy.
Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
[TBL] [Abstract][Full Text] [Related]
33. Identification of neoantigens for individualized therapeutic cancer vaccines.
Lang F; Schrörs B; Löwer M; Türeci Ö; Sahin U
Nat Rev Drug Discov; 2022 Apr; 21(4):261-282. PubMed ID: 35105974
[TBL] [Abstract][Full Text] [Related]
34. Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.
Liu L; Chen J; Zhang H; Ye J; Moore C; Lu C; Fang Y; Fu YX; Li B
Nat Cancer; 2022 Apr; 3(4):437-452. PubMed ID: 35393580
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
36. Emerging strategies for combination checkpoint modulators in cancer immunotherapy.
Popovic A; Jaffee EM; Zaidi N
J Clin Invest; 2018 Aug; 128(8):3209-3218. PubMed ID: 30067248
[TBL] [Abstract][Full Text] [Related]
37. Personalized cancer neoantigen vaccines come of age.
Chu Y; Liu Q; Wei J; Liu B
Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
39. New emerging targets in cancer immunotherapy: the role of neoantigens.
De Mattos-Arruda L; Blanco-Heredia J; Aguilar-Gurrieri C; Carrillo J; Blanco J
ESMO Open; 2020 Apr; 4(Suppl 3):e000684. PubMed ID: 32269031
[TBL] [Abstract][Full Text] [Related]
40. Cancer Neoantigens and Applications for Immunotherapy.
Desrichard A; Snyder A; Chan TA
Clin Cancer Res; 2016 Feb; 22(4):807-12. PubMed ID: 26515495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
